ArticleSurgical endoscopy2026
Assessing the minimal invasiveness of pure single-incision da Vinci SP surgery for right-sided colon cancer: comparative analysis with the da Vinci Xi system using PSM and IPTW.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFew studies have compared the invasiveness and safety of pure single-incision robotic surgery using the da Vinci SP system (SP) without an assistant port with those using the da Vinci Xi system (Xi) for right-sided colon cancer. Surgical invasiveness was assessed using the C-reactive protein/albumin (CRP/Alb) ratio and postoperative pain using the Numerical Rating Scale (NRS).
methodsThis single-center retrospective study included 163 patients who underwent robot-assisted surgery for right-sided colon cancer between October 2022 and August 2025 (SP = 60, Xi = 103). Confounding factors were adjusted using propensity score matching and stabilized inverse probability of treatment weighting based on body mass index (BMI) ≥ 25 kg/m
resultsAfter adjustment, baseline characteristics were well balanced. The SP approach was associated with a shorter incision length (3.0 vs 5.5 cm, p < 0.01) and lower postoperative pain on day 3 (NRS scores 2 vs. 3, p < 0.01). Operative time, postoperative inflammatory response assessed by CRP/Alb ratio, complications, and pathological outcomes were comparable between the groups.
conclusionsPure single-incision robotic surgery using the da Vinci SP system demonstrated comparable short-term safety and oncological adequacy to the Xi system, with modest advantages in incision length and postoperative pain. No clear benefit in systemic inflammatory response was observed, and further validation in larger, prospective, multicenter studies is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.